GSK-3 Inhibitors: Discoveries and Developments

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|11|6|755-763

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.6, 2004-03, pp. : 755-763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GSK3 Inhibitors and Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 9, 2009-08 ,pp. : 1024-1029

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2790-2798

Bentham Science Publishers

Access to resources Recommend Favorite

GSK-3 inhibitors and their potential in the treatment of Alzheimer’s disease

By Kypta Robert M  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 10, 2005-10 ,pp. : 1315-1331

Informa Healthcare

Access to resources Recommend Favorite

QSAR, Docking, and CoMFA Studies of GSK3 Inhibitors

By  

Current Pharmaceutical Design, Vol. 16, Iss. 24, 2010-08 ,pp. : 2666-2675

Bentham Science Publishers

Access to resources Recommend Favorite

Using Small Molecule GSK3β Inhibitors to Treat Inflammation

By  

Current Medicinal Chemistry, Vol. 17, Iss. 26, 2010-09 ,pp. : 2873-2881

Bentham Science Publishers

Access to resources Recommend Favorite